Magnesium Repletion Response: Expected Serum Level Increase
A 2 g intravenous magnesium sulfate dose typically raises serum magnesium by approximately 0.30 mg/dL (0.15 mg/dL per gram) in adults with normal renal function, though this varies significantly based on baseline magnesium level and kidney function.
Quantitative Response Data
The most recent and highest-quality evidence comes from a large multicenter study of 25,637 critically ill patients receiving 54,556 doses of IV magnesium 1. This 2026 study provides the most robust data:
- Overall median increase: 0.15 mg/dL per 1 g IV MgSO₄ (IQR 0.05-0.25)
- For 2 g dose: Expected increase of ~0.30 mg/dL
However, the response is highly dependent on baseline magnesium status:
Response Stratified by Baseline Level
- Severe hypomagnesemia (<1.2 mg/dL): 0.25 mg/dL per gram (0.50 mg/dL for 2 g dose)
- Mild-moderate hypomagnesemia (1.2-1.7 mg/dL): 0.22 mg/dL per gram (0.44 mg/dL for 2 g dose)
- Normal baseline (1.7-2.2 mg/dL): 0.15 mg/dL per gram (0.30 mg/dL for 2 g dose)
This pattern is confirmed by a 2022 prospective study showing 0.13 mg/dL average rise per gram in ICU patients 2.
Critical Modifying Factors
Renal Function Impact
Reduced renal function significantly increases magnesium retention 1, 2:
- eGFR ≥90 mL/min/1.73m²: 0.10 mg/dL rise per gram (0.20 mg/dL for 2 g)
- eGFR 30-89 mL/min/1.73m²: 0.15 mg/dL rise per gram (0.30 mg/dL for 2 g)
- eGFR <30 mL/min/1.73m²: Even greater retention expected
The 2026 study identified reduced renal function as a significant predictor of greater response (β = 0.2557; p < 0.001) 1.
Route of Administration
Intravenous administration produces greater and more rapid elevations compared to oral replacement 3. At baseline levels of 1.4-1.8 mg/dL:
- IV magnesium sulfate 2 g: Larger, faster increase
- Oral magnesium oxide 800-1600 mg: Consistent median increase of only 0.1 mg/dL
Clinical Application Algorithm
For a patient with baseline serum Mg ~1.7 mg/dL and normal renal function:
- Expected post-repletion level: 1.7 + 0.30 = ~2.0 mg/dL
- Recheck timing: 6-24 hours post-infusion for accurate assessment 3
- If eGFR 30-89: Expect higher rise (~0.40 mg/dL total)
- If severe hypomagnesemia: May need additional doses as response is greater but starting deficit is larger
Important Caveats
Measurement Timing
The degree of SMC change is significantly influenced by when you measure after magnesium administration 3. Optimal timing is 6-24 hours post-infusion.
Serum Limitations
Serum magnesium is a poor indicator of total body magnesium status 4, 5. The guidelines emphasize:
- Only 1% of total body magnesium is in serum 6
- 24-hour urinary magnesium is more reliable for assessing true depletion 5
- Intracellular deficiency can exist with normal serum levels 4
Concurrent Factors Affecting Response
- Loop diuretics: Increase renal magnesium wasting, reducing net gain 3
- PPI therapy: Contributes to ongoing magnesium depletion 5
- Hypocalcemia: May not correct until magnesium is repleted (magnesium is required for PTH function) 4
Dosing Considerations in Special Populations
For cardiac arrest/severe cardiotoxicity: 1-2 g IV MgSO₄ bolus is recommended for torsades de pointes 7.
For chronic intestinal failure: Oral organic magnesium salts (gluconate, citrate) are preferred over inorganic salts due to slower dissociation and less diarrhea 5.
Practical Bottom Line
With 2 g IV magnesium sulfate in your scenario (baseline 1.7 mg/dL, normal renal function), expect serum magnesium to rise to approximately 2.0 mg/dL when measured 6-24 hours post-infusion. Lower baseline levels or reduced kidney function will produce larger increases, while concurrent diuretic use may blunt the response. Consider that achieving normal serum levels does not guarantee correction of tissue/intracellular deficiency 4, 6.